Bremer T, Mittal K, Shah C, Vicini F, et al. Development and cross-validation of a novel multi-omic assay to assess locoregional recurrence risk and adjuvant therapy benefit in early-stage hormone receptor positive invasive breast cancer patients. Breast Cancer Res 2026 Feb 18. doi: 10.1186/s13058-026-02237.
PMID: 41709333